ArticleBritish journal of cancer2003

Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen.

J Kupryjańczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.